Author Question: The nurse would administer desmopressin (DDAVP) cautiously, with careful monitoring, to the patient ... (Read 61 times)

stephzh · **on:** Jul 23, 2018

The nurse would administer desmopressin (DDAVP) cautiously, with careful monitoring, to the patient with what co-morbidity? (Select all that apply.)

A) Hyponatremia
B) Asthma
C) Severe renal dysfunction
D) Gastrointestinal (GI) disease
E) Epilepsy

Question 2

A patient who is experiencing severe pain is administered a narcotic. What would the nurse write in the plan of care as a desirable and measurable outcome for this patient?

A) A shorter period of time between requests for medication
B) Reduced complaints about limited movement
C) Lack of restlessness and ability to sustain one position
D) Increased autonomy in providing AM care

KKcool · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

A, B, E
Feedback:
Caution should be used with any known vascular disease because of its effects on vascular smooth muscle, epilepsy, asthma, and with hyponatremia, which could be exacerbated by the effects of the drug. The drug is contraindicated and should not be used in patients with severe renal dysfunction. GI disease is not a caution or contraindication.

Answer to Question 2

D
Feedback:
Monitor patient response to the drug (e.g., relief of pain, sedation).When pain is being adequately managed with opioid therapy, a desirable and measurable outcome would be that the patient is able to be more autonomous in providing care in the morning. Shorter periods between requests for medication would not be a desirable outcome because it is not an indicator of pain control given that some patients are reluctant to ask for medicine even though they are in pain. Patients in pain tend not to move for fear of exacerbating the pain, so lack of movement can be an indication the patient is in pain. Just because the patient does not complain of pain doesn't mean he isn't experiencing pain.